Development of accuracy enhancement system for boron meters using multisensitive detector for reactor safety

Boric acid is used as a coolant for pressurized-water reactors, and the degree of burnup is controlled by the concentration of boric acid. Therefore, accurate measurement of the concentration of boric acid is an important factor in reactor safety. An improved system was proposed for the accurate determination of boron concentration. A new boron-concentration measurement technique, called multisensitive detection, was developed to improve the measurement accuracy of boron meters. In previous studies, laboratory-scale experiments were performed based on different sensitivity detectors, confirming a 65% better accuracy than conventional single-detector boron meters. Based on these experimental results, an experimental system simulating the coolant-circulation environment in the reactor was constructed; accuracy analysis of the boron meter with a multisensitivity detector was performed at the actual coolant pressure and temperature. In this study, the boron concentration conversion equation was derived from the calibration test, and the accuracy of the boron concentration conversion equation was examined through a repeatability test. Through the experiment, it was confirmed that the accuracy was up to 87.5% higher than the conventional single-detector boron meter

Optimization of airborne alpha beta detection system modeling using MCNP simulation

An airborne alpha beta detection system using passivated implanted planar silicon (PIPS) detector was modeled with the MCNP6 code and its resolution and detection efficiency were analyzed. Simulation of the resolution performed using the Gaussian energy broadening (GEB) function showed that the full width at half maximum (FWHM) of 35.214 keV for alpha particles was within 34-38 KeV, which is the FWHM range of the actual detector, and the FWHM of 15.1 keV for beta particles was constructed with a similar model to 17 keV, which is the FWHM range of an actual detector. In addition, the detection efficiency and the resolution were simulated according to the distance between the detector and the air filter. When the distance was decreased to 0.2 cm from 0.8 cm, the efficiency of the alpha and beta particles detection decreased from 5.33% to 4.89% and from 5.64% to 4.27%, respectively, and the FWHM of the alpha and beta particles improved from 40.9 KeV to 29.84 keV and 25.76 keV-13.27 keV, respectively. (C) 2019 Korean Nuclear Society, Published by Elsevier Korea LLC

Spectral resolution evaluation by MCNP simulation for airborne alpha detection system with a collimator

In this study, an airborne alpha detection system, which consists of a passivated implanted planar silicon (PIPS) detector and an air filter, was developed. A collimator applied to the alpha detection system showed an enhancement in resolution and a degradation in detection efficiency. The resolution and detection efficiency were compared and analyzed to evaluate the performance of the collimator. Thus, the resolution was found to be more important than the efficiency as a determining factor of the detection system performance, from the viewpoint of radionuclide identification. The performance was evaluated on three properties of the collimator: hole shape, hole length, and the ratio between the hole and frame pitches. From the hole shape performance evaluation, a hexagonal collimator showed the highest resolution. Further, the collimator with a hole pitch of 14 mm was found to have the highest resolution while that with a frame pitch of 4-6 mm (i.e., 1.2-1.4 times longer than the hole pitch) showed the highest resolution. ? 2020 Korean Nuclear Society, Published by Elsevier Korea LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients With Diabetes Mellitus The DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients)

ObjectivesWe sought to evaluate the impact of cilostazol on neointimal hyperplasia after drug-eluting stent (DES) implantation in patients with diabetes mellitus (DM).BackgroundAlthough cilostazol has reduced the extent of neointimal hyperplasia and restenosis in patients after bare-metal stent implantation, it is not known whether this effect occurs after DES implantation in diabetic patients.MethodsThis randomized, multicenter, prospective study compared triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol, triple group, n = 200) and dual antiplatelet therapy (aspirin and clopidogrel, standard group, n = 200) for 6 months in patients with DM receiving DES. The primary end point was in-stent late loss at 6 months.ResultsThe 2 groups had similar baseline clinical and angiographic characteristics. The in-stent (0.25 ± 0.53 mm vs. 0.38 ± 0.54 mm, p = 0.025) and in-segment (0.42 ± 0.50 mm vs. 0.53 ± 0.49 mm, p = 0.031) late loss were significantly lower in the triple versus standard group, as were 6-month in-segment restenosis (8.0% vs. 15.6%, p = 0.033) and 9-month target lesion revascularization (TLR) (2.5% vs. 7.0%, p = 0.034). At 9 months, major adverse cardiac events, including death, myocardial infarction, and TLR, tended to be lower in the triple than in the standard group (3.0% vs. 7.0%, p = 0.066). Multivariate analysis showed that sirolimus-eluting stents and the use of cilostazol were strong predictors of reduced restenosis or TLR.ConclusionsTriple antiplatelet therapy after DES implantation decreased angiographic restenosis and extent of late loss, resulting in a reduced risk of 9-month TLR compared with dual antiplatelet therapy in diabetic patients

Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Abstract Introduction Inflammation has been implicated in cancer aggressiveness. As transglutaminase 2 (TG2), which has been associated with inflammatory signaling, has been suggested to play a role in tumor behavior, we propose that TG2 may be an important linker inducing interleukin (IL)-6-mediated cancer-cell aggressiveness, including distant hematogenous metastasis. Methods To investigate the role for TG2 and IL-6, TG2-knocked-down and IL-6-knocked-down cancer cells were generated by using shRNA. Human breast cancer cell xenograft model in highly immunocompromised mice and human advanced breast cancer primary tumor tissue microarrays were used in this study. Results IL-6 production in human breast cancer cells was dependent on their TG2 expression level. In vitro tumor-sphere formation was dependent on TG2 and downstream IL-6 production from cancer cells. Primary tumor growth in the mammary fat pads and distant hematogenous metastasis into the lung was also dependent on TG2 and downstream IL-6 expression levels. The effect of TG2 expression on human breast cancer distant metastasis was investigated by analyzing a tissue microarray of primary tumors from 412 patients with their clinical data after 7 years. TG2 expression in primary tumor tissue was inversely correlated with recurrence-free survival (P = 0.019) and distant metastasis-free survival (DMFS) (P = 0.006) in patients with advanced breast cancer. Furthermore, by using public datasets that included a total of 684 breast cancer patients, we found that the combined high expression of TG2 and IL-6 was associated with shorter DMFS, compared with the high expression of IL-6 only (P = 0.013). Conclusions We provide evidence that TG2 is an important link in IL-6-mediated tumor aggressiveness, and that TG2 could be an important mediator of distant metastasis, both in a xenograft animal model and in patients with advanced breast cancer